Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus | Zendy

Florian P. Maurer | Zendy; Claudio Castelberg | Zendy; Catherine Quiblier | Zendy; Erik C. Böttger | Zendy; Ákos Somoskövi | Zendy

Open Access

Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus

Author(s) -

Florian P. Maurer,

Claudio Castelberg,

Catherine Quiblier,

Erik C. Böttger,

Ákos Somoskövi

Publication year - 2014

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dku007

Subject(s) - clarithromycin , azithromycin , mycobacterium abscessus , microbiology and biotechnology , mycobacterium chelonae , broth microdilution , antibiotics , drug resistance , minimum inhibitory concentration , antibacterial agent , mycobacterium , 23s ribosomal rna , medicine , biology , bacteria , gene , genetics , ribosome , rna

The ribosomal methylase Erm(41) confers inducible resistance to macrolides in Mycobacterium abscessus. The aim of this work was to systematically study and compare drug susceptibility to clarithromycin and azithromycin in M. abscessus and Mycobacterium chelonae clinical isolates with a particular focus on inducible drug resistance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research